Table 3 Surface phenotypes of PBLs pre- and postvaccination with dendritic cells
| Â | CD3(%) | CD4(%) | CD8(%) | CD16(%) | CD19(%) | CD56(%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post |
3 | 70.38 | 63.32 | 37.52 | 27.16 | 30.02 | 37.52 | 6.4 | 7.92 | 20.26 | 23.46 | 19.34 | 23.2 |
5 | 41.34 | 41.96 | 30.9 | 31.28 | 24.84 | 43.6 | 41.24 | 33.82 | 11.32 | 17 | 47.42 | 53.06 |
6 | 66 | 66.56 | 36.3 | 29.8 | 39.8 | 48.14 | 17.5 | 19.92 | 5.5 | 3.34 | 28.1 | 28.36 |
7 | 69.14 | 64.28 | 35.14 | 28.22 | 47.64 | 47.14 | 15.88 | 17.52 | 11.98 | 15.5 | 20.14 | 23.64 |
8 | 78.68 | 71.78 | 45.16 | 40.48 | 35.26 | 43.04 | 2.9 | 15.28 | 6.44 | 24.44 | 15.36 | 22.18 |
